1Clinical and Laboratory Standards Institute. M100-S21 Performance standards for antimicrobial susceptibility testing; Twenty-first information supplement. Wayne PA, 2011.
3Beir~Io EM, Furtado JJ, Girardello R, et al. Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil[J].Braz J Infect Dis, 2011, 15(1): 69.
4Ababneh M, Harpe S, Oinonen M, et al. Trends in aminoglycoside use and gentamicin-resistant gram- negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship[J].Infect Control HospEpidemiol, 2012, 33(6): 594-601.
5Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)[J].Antimicrob Resist Infect Control, 2012, 1(1): 9.
6Ma L, Lu PL, Siu LK, et al. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002- 2009 [J]. J Med Microbiol, 2013, 62(Pt 1): 101-107.
7Ikeda Y, Mamiya T, Nishiyama H, et al. A permission system for carbapenem use reduced incidence of drug- resistant bacteria and cost of antimicrobials at a general hospital in Japan[J]. Nagoya J Med Sci, 2012, 74(1-2): 93-104.
8Peripi SB, Thadepalli VG, Khagga M, et al. Profile of antibiotic consumption, sensitivity and resistance in an urban area of Andhra Pradesh,India[J]. Singapore Med J, 2012, 53(4): 268-272.
9Sabatier C,Peredo R,Villagr6 A,et al. Community -ac- quired pneumonia: a 7-years descriptive study. Usefulness of the IDSA/ATS 2007 in the assessment of ICU admission[J]. Med Intensiva, 2010,34(4) :237-245.
